Biogenic Silver Nanoparticles Can Control Toxoplasma gondii Infection in Both Human Trophoblast Cells and Villous Explants

The combination of sulfadiazine and pyrimethamine plus folinic acid is the conventional treatment for congenital toxoplasmosis. However, this classical treatment presents teratogenic effects and bone marrow suppression. In this sense, new therapeutic strategies are necessary to reduce these effects...

Descripción completa

Detalles Bibliográficos

Autores principales:	Idessania Nazareth Costa, Mayara Ribeiro, Priscila Silva Franco, Rafaela José da Silva, Thádia Evelyn de Araújo, Iliana Claudia Balga Milián, Luana Carvalho Luz, Pâmela Mendonça Guirelli, Gerson Nakazato, José Roberto Mineo, Tiago W. P. Mineo, Bellisa Freitas Barbosa, Eloisa Amália Vieira Ferro
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Frontiers Media S.A. 2021-01-01
Colección:	Frontiers in Microbiology
Materias:	Toxoplasma gondii trophoblast placenta nanoparticles treatment congenital toxoplasmosis
Acceso en línea:	https://www.frontiersin.org/articles/10.3389/fmicb.2020.623947/full
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!